Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

What's next for biopharma Q3 earnings
Biopharma Dive
Sat, 10/21/17 - 09:50 pm
Tags:
earnings, Amgen, Bristol-Myers Squibb, Celgene, GSK, Gilead Sciences, AbbVie, Merck, Shire
Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September
Fierce Pharma
Mon, 10/9/17 - 11:24 am
Tags:
Pfizer, Lyrica, AbbVie, Humira, drug ads, television ads
AbbVie hit with $140M verdict in second bellwether AndroGel case
Fierce Pharma
Fri, 10/6/17 - 11:39 am
Tags:
AbbVie, Androgel, heart attacks, testosterone
3 Big Pharma Stocks Set to Succeed
Motley Fool
Thu, 10/5/17 - 09:36 am
Tags:
AbbVie, Humira, patents, Allergan, Botox, Celgene, Revlimid
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
Tags:
biotech, Axovant Sciences, intepirdine, SAGE Therapeutics, brexanolone, AbbVie, risankizumab, Global Blood Therapeutics, GBT-440, DBV Technologies, Viaskin Peanut, Cytokinetics, Amicus Therapeutics, ATB200, Spark Therapeutics, Bluebird Bio, Revance Therapeutics, RT002
Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
RAPS.org
Mon, 10/2/17 - 11:18 am
Tags:
AbbVie, Amgen, Humira, biosimilars, Medicare, Medicaid, CMS
AbbVie: Better Late Than Never
Barron's
Mon, 10/2/17 - 10:40 am
Tags:
AbbVie
Merck Hepatitis C exit could lift the space’s two remaining drugmakers
Marketwatch
Sun, 10/1/17 - 10:04 am
Tags:
Merck, hepatitis C, AbbVie, Gilead Sciences
How Good Is AbbVie's Humira Deal With Amgen?
Motley Fool
Fri, 09/29/17 - 10:06 am
Tags:
AbbVie, Amgen, Humira, biosimilars, Amjevita
Pharma's pricing pledges? Maybe they weren't such a good idea in the first place, experts say
Fierce Pharma
Thu, 09/28/17 - 09:55 am
Tags:
drug pricing, AbbVie
Under Amgen and AbbVie agreement, rival drug to AbbVie's Humira expected to launch in 2023
Marketwatch
Thu, 09/28/17 - 09:50 am
Tags:
Amgen, AbbVie, Humira, Amgevita, biosimilars, drug launches
What pledge? AbbVie executives may back off their vow to limit price hikes: report
Fierce Pharma
Mon, 09/25/17 - 07:34 pm
Tags:
AbbVie, drug pricing
AbbVie's Unfazed by the Risk of Generic Humira
Motley Fool
Mon, 09/25/17 - 09:45 am
Tags:
AbbVie, generics, Humira
AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo
Fierce Biotech
Sat, 09/23/17 - 10:02 am
Tags:
AbbVie, Bristol-Myers Squibb, Opdivo, ABBV-399, antibody-drug conjugate, non-small cell lung cancer
AbbVie’s top execs paint a rosy pic of the mega-blockbuster future looming for Humira and PhIII drugs
Endpoints
Fri, 09/22/17 - 09:19 am
Tags:
AbbVie, Humira, Rick Gonzalez
AbbVie, Roche to seek broader market for leukemia drug after trial success
BioPharma Dive
Tue, 09/19/17 - 10:23 pm
Tags:
AbbVie, Roche, clinical trials, Venclexta, Rituxan, chronic lymphocytic leukemia
Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?
Motley Fool
Sat, 09/16/17 - 12:01 pm
Tags:
AbbVie, Humira, Celgene, Revlimid, Bristol-Myers Squibb, Opdivo, Merck, Keytruda, Biogen, aducanumab
AbbVie keen on JAK inhibitor despite safety concerns
BioPharma Dive
Tue, 09/12/17 - 04:22 pm
Tags:
AbbVie, JAK inhibitors, Upadacitinib, ABT-494, rheumatoid arthritis
AbbVie and Pfizer hover at top, J&J Stelara surges in August TV pharma ad spend
Fierce Pharma
Mon, 09/11/17 - 09:06 pm
Tags:
AbbVie, Pfizer, JNJ, drug ads, television ads
AbbVie reports two patient deaths in rheumatoid arthritis study
Yahoo/Reuters
Mon, 09/11/17 - 09:25 am
Tags:
AbbVie, clinical trials, rheumatoid arthritis, Upadacitinib, ABT-494

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.